Fiche du document
9 novembre 2020
- doi: 10.1016/j.ccell.2020.09.018
- issn: 1535-6108
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ccell.2020.09.018
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/33049215
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1878-3686
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_5F36B8AB68754
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Sujets proches
Carcinoma Cancers Malignancy (Cancer) Malignant tumorsCiter ce document
Z. Bakouny et al., « COVID-19 and Cancer: Current Challenges and Perspectives. », Serveur académique Lausannois, ID : 10.1016/j.ccell.2020.09.018
Métriques
Partage / Export
Résumé
Patients with cancer have been disproportionately affected by the COVID-19 pandemic. This effect has included the adverse outcomes in patients with cancer who develop COVID-19, the impact of the COVID-19 pandemic on the delivery of cancer care, and the severe disruption to cancer research. However, patients with cancer are a heterogeneous population, and recent studies have now documented factors that allow risk stratification of patients with cancer in order to optimize care. In this review, we highlight data at the intersection of COVID-19 and cancer, including the biological interplay between the two diseases and practical recommendations for the treatment of patients with cancer during the pandemic. We additionally discuss the potential long-lasting impact of the pandemic on cancer care due to its deleterious effect on cancer research, as well as biological insights from the cancer research community that could help develop novel therapies for all patients with COVID-19.